PharmEasy IPO Date, Review, Price, Form & Market Lot Details

API Holdings Limited formerly known as ‘PharmEasy’is established in 2019. Siddharth Shah, Harsh Parekh, Hardik Dedhia, Dharmil Sheth and Dhaval Shah are the company promoters.

PharmEasy IPO: API Holdings operate an integrated, end-to-end business that aims to provide solutions for healthcare needs of consumers across the following critical stages. A. providing digital tools and information on illness and wellness, B. offering teleconsultation,
C. offering diagnostics and radiology tests, and D. delivering treatment protocols including products and devices.

They have working in online as well as offline industries with their brands like Docon, PharmEasy, Medlife, Thyrocare, Aknamed, Marg ERP Limited (49.17% stake),redbook, retailio.

Requirement of funds

  • 1. Prepayment or repayment of all or a portion of certain outstanding borrowings availed by our Company and certain
    of our Subsidiaries;
  • 2. Funding organic growth initiatives;
  • 3. Pursuing inorganic growth through acquisitions and other strategic initiatives; and
  • 4. General corporate purposes.

The company will use 1,929 ₹ crore from the IPO proceeds to repay or prepay borrowings and 1,259 ₹ crore to fund organic growth initiatives. It will also allocate ₹1,500 crore on inorganic growth opportunities through acquisitions and other strategic initiatives.

Read : Upcoming IPO

PharmEasy IPO Details
IPO Opening Dates Update Soon
IPO Closing Dates Update Soon
Price Band Update Soon
Offer For Sale Update Soon
Fresh issue Update Soon
Total size 6250 Crore
Minimum bid (lot size) Update Soon
Face Value 1 Rs share
Retail Allocation 10%
QIB Allocation 75%
NII Allocation 15%
Listing On NSE, BSE
PharmEasy IPO Market Lot
Lot No of Shares Amount
Minimum Update Soon Update Soon Update Soon
Maximum Update Soon Update Soon Update Soon

Financial Record of the last year (In Millions)

Financial Period : 30-Jun-21
Total Assets : 980.39
Total Revenue : 11,968.08
Loss After Tax : (3,138.91)
Earnings Per Share (EPS) FY2021 : (77.20) INR

PharmEasy IPO DRHP


PharmEasy IPO Review

Avoid (Based on Financial Information)

PharmEasy IPO Allotment Date & Details

Allotment Date Update Soon
Initiation of refunds Update Soon
Transfer of shares to Demat accounts Update Soon
Listing Date Update Soon

Registrar of PharmEasy

Link Intime India Private Limited
C-101, 247 Park, L B S Marg,
Vikhroli (West), Mumbai 400 083,
Maharashtra, India
Tel: +91 22 4918 6000
E-mail: [email protected]
SEBI Registration No.:INR000004058

PharmEasy Contact Details

902, 9th Floor, Raheja Plaza 1,
B-Wing, Opposite R-City Mall,
L.B.S. Marg, Ghatkopar West,
Mumbai 400 086, Maharashtra,
India; Tel: +91 22 6255 6255;
Corporate Identity Number: U60100MH2019PLC323444

PharmEasy IPO Lead Managers

Kotak Mahindra Capital Company Limited
Morgan Stanley India Company Private Limited
BofA Securities India Limited
Citigroup Global Markets India Private Limited
JM Financial Limited

Leave a Reply